Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma (NCT04362007) | Otsuka Pharmaceutical Co., Ltd. | 2020-07-14 |
Track Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL) automatically
Every clearance here is in the API, with alerts when new ones post.